← Evidence map

ArticleOncotarget2024

Next-generation cell-penetrating antibodies for tumor targeting and RAD51 inhibition.

Madison Rackear et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39352803